Dune Medical Plans Summer Submission For Breast Cancer Probe PMA
This article was originally published in The Gray Sheet
Executive Summary
Dune Medical will submit a PMA application this summer for its MarginProbe intraoperative real-time margin detection system for breast cancer surgery, according to Bill Densel, the firm's U.S. president
You may also be interested in...
Intraoperative Probe Helps Identify Tumor Malignancy In Real Time
A novel handheld device that detects differences in electromagnetic properties between malignant and benign tissue may provide real-time intraoperative tumor analysis, new research suggests
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.